Recently, boron neutron capture therapy (BNCT) has been attracting attention as a
minimally invasive cancer treatment. In 2020, the accelerator-based BNCT with L-BPA …

10 B-Borono-2-18 F-fluoro-l-phenylalanine (18 F-FBPA) was developed for monitoring the
pharmacokinetics of 4-10 B-borono-l-phenylalanine (10 B-BPA) used in boron neutron …

In the current clinical boron neutron capture therapy (BNCT), p-boronophenylalanine (BPA)
has been the most powerful drug owing to its ability to accumulate selectively within cancers …

A boron neutron capture therapy (BNCT) system, using boron-10-introduced agents coupled
with companion diagnostics, is anticipated as a promising cancer theranostic. Thus, this …

Boron neutron capture therapy shows is a promising approach to cancer therapy, but the
delivery of effective boron agents is challenging. To address the requirements for efficient …

Boron neutron capture therapy (BNCT) is a tumour selective particle radiotherapy, based on
the administration of boron carriers incorporated preferentially by tumour cells, followed by …

Boron neutron capture therapy (BNCT) is a unique anticancer technology that has
demonstrated its efficacy in numerous phase I/II clinical trials with boronophenylalanine …

Purpose: To evaluate the efficacy of boron neutron capture therapy (BNCT) for a heterotopic
U87 glioblastoma model in SCID mice using boron phenylalanine (BPA), sodium …

Boron neutron capture therapy (BNCT) is a binary cancer therapy that involves boron
administration and neutron irradiation. The nuclear reaction caused by the interaction of …

Boron neutron capture therapy (BNCT) is a highly targeted, selective and effective technique
to cure various types of cancers, with less harms to the healthy cells. In principle, BNCT …